Global Pharmaceuticals & Biotech High ROE Growth Engines

Incyte

Market Cap: US$25.8b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Exelixis

Market Cap: US$13.3b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Orion Oyj

Market Cap: €11.1b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

CSPC Innovation Pharmaceutical

Market Cap: CN¥68.2b

Engages in the research and development, production, and sales of biopharmaceuticals, functional foods, and raw materials in China and internationally.

Shanghai Allist Pharmaceuticals

Market Cap: CN¥52.4b

A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.

Sunshine Guojian Pharmaceutical (Shanghai)

Market Cap: CN¥42.7b

A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.

Abbott India

Market Cap: ₹557.7b

Operates as a pharmaceutical company in India.

3SBio

Market Cap: HK$44.4b

An investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People’s Republic of China, the United States, and internationally.

GlaxoSmithKline Pharmaceuticals

Market Cap: ₹491.2b

Manufactures, distributes, and trades in pharmaceuticals in India and internationally.

ACADIA Pharmaceuticals

Market Cap: US$5.1b

A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.

Suzhou Zelgen Biopharmaceuticals

Market Cap: CN¥34.1b

Engages in the research, development, manufacture, sale, and distribution of medicines in the People's Republic of China.

Ajanta Pharma

Market Cap: ₹454.7b

A pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages.

SK Biopharmaceuticals

Market Cap: ₩6.6t

A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.

Sumitomo Pharma

Market Cap: JP¥633.2b

Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.

Xiamen Amoytop Biotech

Market Cap: CN¥25.3b

Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.

Laboratorios Farmaceuticos Rovi

Market Cap: €3.1b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

Neuland Laboratories

Market Cap: ₹298.9b

Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.

Jamjoom Pharmaceuticals Factory

Market Cap: ر.س9.9b

Engages in the manufacture and distribution of pharmaceutical and consumer products in the Kingdom of Saudi Arabia, Gulf, Iraq, Egypt, North Africa, and internationally.

CareDx

Market Cap: US$2.4b

Provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.

ADMA Biologics

Market Cap: US$2.2b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Shenyang Xingqi PharmaceuticalLtd

Market Cap: CN¥14.2b

Engages in the research, development, production, and sale of ophthalmic drugs in the People’s Republic of China.

HBM Holdings

Market Cap: HK$13.8b

A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.

Innoviva

Market Cap: US$1.5b

Operates as a biopharmaceutical company in the United States and internationally.

MeiraGTx Holdings

Market Cap: US$1.4b

A clinical-stage genetic medicines company, focusing on developing treatments for patients with serious diseases.

CORONA Remedies

Market Cap: ₹131.0b

A pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products.

ChemoMetec

Market Cap: DKK 8.5b

Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.

BioGaia

Market Cap: SEK 11.6b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

Basilea Pharmaceutica

Market Cap: CHF 813.6m

A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.

Oscotec

Market Cap: ₩1.4t

Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.

Soho Global Health

Market Cap: Rp15.2t

Together with its subsidiaires, operates as a healthcare company in Indonesia.

Zevra Therapeutics

Market Cap: US$706.1m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

CorMedix

Market Cap: US$641.5m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

Rafa Laboratories

Market Cap: ₪1.5b

A pharmaceutical company, manufactures, markets, and distributes prescription (Rx) and over-the-counter (OTC) medicines in Israel.

Onconic Therapeutics

Market Cap: ₩659.3b

Engages in the research and development of anti-cancer therapy in South Korea.

Q32 Bio

Market Cap: US$472.1m

A clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction.

DHG Pharmaceutical

Market Cap: ₫12.4t

Engages in the manufacture and sale of pharmaceutical products in Vietnam.